Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
8.95 USD -0.40 ( 4.28%)
Last update at 2026-11-11T21:03:00Z
VOLUME
350355
Market Cap
231.30M

Momentum Score

…

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
8.88
Low
9.83
High
52 Week Price Range
6.92
Low
16.64
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
9.35
Dividend Yield
-
Revenue TTM
78.21M
Revenue Per Share
4.50
Gross Profit TTM
38.97M
Debt / Equity
0.29
ROE
-14.66%
Net Debt
22.97M
ROCE
-7.43%
Diluted EPS TTM
-1.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.44M 0.38M -2.21M -4.04M 0.23M
Net income -10.59M 0.27M -2.38M -3.14M 0.23M
Selling general administrative 49.24M 33.19M 24.16M 17.85M 11.71M
Selling and marketing expenses - 1.03M 0.62M 0.71M 0.30M
Gross profit 38.97M 35.64M 24.11M 15.44M 12.21M
Reconciled depreciation 2.02M 1.97M 1.97M 1.18M 0.32M
Ebit -12.29M 0.48M -1.89M -3.69M 0.18M
Ebitda -10.27M 2.45M 0.08M -1.78M 0.50M
Depreciation and amortization 2.02M 1.97M 1.97M 1.92M 0.32M
Non operating income net other 0.02M 0.02M -0.07M -0.35M 0.05M
Operating income -12.29M 0.48M -1.89M -3.69M 0.18M
Other operating expenses 74.74M 60.93M 45.45M 28.29M 21.03M
Interest expense 0.85M 0.12M 0.07M 0.98M 0.00M
Tax provision 0.00M 0.00M 0.00M -0.90M 0.00M
Interest income 0.85M 0.02M 0.07M 0.29M 0.05M
Net interest income 0.85M 0.02M 0.07M 0.29M 0.05M
Income tax expense -0.85M 0.10M 0.18M -0.90M 0.05M
Total revenue 62.45M 61.29M 43.31M 24.60M 21.21M
Total operating expenses 51.26M 35.28M 26.24M 19.13M 12.03M
Cost of revenue 23.48M 25.65M 19.21M 9.16M 9.00M
Total other income expense net 0.85M -0.10M -0.32M -0.35M -0.61M
Net income from continuing ops 0.38M 0.38M -2.21M -3.14M 0.23M
Net income applicable to common shares 0.38M 0.38M -2.21M -3.14M 0.23M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 183.37M 134.65M 140.99M 60.33M 56.64M
Intangible assets 49.40M 13.02M 10.65M 12.12M 13.94M
Other current assets 3.19M 0.47M 5630655.00M 4.46M 0.87M
Total liab 56.82M 8.54M 9.61M 10.35M 11.78M
Total stockholder equity 126.55M 126.11M 131.38M 49.97M 44.86M
Other current liab 13.26M 2.60M 2.90M 4.03M 3.30M
Common stock 0.02M 0.02M 0.02M 0.02M 0.01M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.01M
Retained earnings -64.26M -46.69M -35.25M -35.63M -33.42M
Other liab - - - - 5.22M
Good will 78.36M 22.67M 14.74M 14.74M 14.74M
Other assets 0.00M 0.01M 0.01M 0.01M 0.08M
Cash 13.85M 18.21M 84.68M 10.52M 18.85M
Total current liabilities 17.88M 8.40M 9.37M 10.03M 6.11M
Current deferred revenue 0.17M 0.16M 1.39M 0.29M 0.58M
Net debt 22.97M -17.97M -84.35M -10.07M -18.29M
Short term debt 2.22M 0.09M 0.09M 0.12M 0.12M
Short long term debt 2.00M - - - -
Short long term debt total 36.82M 0.23M 0.33M 0.45M 0.56M
Other stockholder equity 190.79M 172.78M 166.62M 85.59M 78.27M
Property plant equipment - 0.14M 0.47M 0.15M 0.74M
Total current assets 54.33M 98.58M 115.11M 32.86M 27.14M
Net tangible assets - 131.38M 105.99M 49.97M 16.18M
Short term investments 0.00M 55.93M - - -
Net receivables 37.29M 22.16M 24.80M 17.89M 7.42M
Long term debt 34.23M - - - -
Inventory - 1.81M -5630649.37M - -
Accounts payable 2.23M 5.54M 4.99M 5.59M 2.11M
Accumulated other comprehensive income 0.00M - - - -0.15M
Common stock total equity - 0.02M 0.02M 0.02M 0.01M
Retained earnings total equity - -35.25M -35.25M -35.63M -33.42M
Treasury stock - -0.00M - - -
Non currrent assets other 0.57M 0.01M 0.01M 0.01M 0.08M
Non current assets total 129.04M 36.07M 25.87M 27.47M 29.50M
Capital lease obligations 0.59M 0.23M 0.33M 0.45M 0.56M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -55.93M -0.49M -0.12M -10.58M -5.69M
Change to liabilities 1.45M 1.09M 1.14M -0.62M 0.10M
Total cashflows from investing activities -0.49M -0.49M -0.12M -10.58M -5.69M
Total cash from financing activities -18.95M 73.92M -1.90M 22.18M 8.69M
Change to operating activities 1.96M -1.41M 1.14M -1.17M 0.64M
Net income -11.44M 0.38M -2.21M -3.14M 0.23M
Change in cash -66.47M 74.16M -8.34M 9.94M 3.79M
Begin period cash flow 84.68M 10.52M 18.85M 8.91M 5.12M
End period cash flow 18.21M 84.68M 10.52M 18.85M 8.91M
Total cash from operating activities 10.65M 0.73M -6.31M -1.66M 0.79M
Issuance of capital stock 0.00M 70.67M 0.00M 21.30M 8.16M
Depreciation 2.02M 1.97M 1.97M 1.28M 0.32M
Other cashflows from investing activities -0.39M -0.39M -0.06M -10.49M -5.65M
Change to inventory - -0.82M -2.21M -0.88M -0.09M
Change to account receivables 2.28M -6.99M -10.67M -0.55M -2.79M
Sale purchase of stock -20.02M 75.54M 2.49M 22.18M 8.69M
Other cashflows from financing activities -70670.46M 3.25M -1.90M 0.88M 0.52M
Change to netincome 0.12M 5.69M 3.62M 2.18M 1.87M
Capital expenditures 0.24M 0.49M 0.12M 1.59M 0.09M
Change receivables -6.99M -6.99M -10.67M -0.63M -2.79M
Cash flows other operating 5.77M 5.77M 1.80M -0.63M 1.07M
Cash and cash equivalents changes 74.16M 74.16M -8.34M 9.94M 3.79M
Change in working capital 3.96M -7.31M -9.69M -1.80M -2.27M
Stock based compensation 15.75M 5.49M 3.17M 2.26M 1.86M
Other non cash items 0.36M 0.12M 0.25M 0.64M 0.66M
Free cash flow 10.41M 0.24M -6.44M -3.25M 0.70M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OPRX
OPTIMIZERx Corp
-0.40
4.28%
8.95 - 30.77 3.11 1.68 2.10 -9.09
VEEV
Veeva Systems Inc Class A
-0.78
0.26%
304.77 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-2.18
1.51%
141.82 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
-1.11
1.38%
79.43 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.11
1.88%
5.73 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

OPTIMIZERx Corp

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

400 Water Street, Rochester, MI, United States, 48307

248 651 6568

135

Name Title Year Born
Mr. William J. Febbo CEO & Director 1969
Mr. Edward Stelmakh C.M.A., M.B.A., MBA CFO & COO 1966
Ms. Marion K Odence-Ford Gen. Counsel & Chief Compliance Officer 1965
Mr. Douglas P. Baker Exec. VP of Fin. & Accounting 1957
Mr. Andrew Jacob D'Silva Sr. VP of Corp. Fin. NA
Mr. Todd Inman Chief Technology Officer 1955
Maira Alejandra Media Relations Mang. NA
Ms. Sheryl Kearney HR Mang. NA
Mr. Terence J. Hamilton Sr. VP of Pharma 1965
Mr. Stephen L. Silvestro Chief Commercial Officer 1978

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…